SomaLogic Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SomaLogic Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3448
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies and aptamers, which is used in clinical diagnosis of EDTA plasma, citrate plasma, serum, CSF, tissue homogenate, cell lysates and conditioned cell media. SomaLogic’s SOMAscan assay is a protein biomarker discovery and development tool for protein measurement solutions. It offers protein-measurement assays, kits, and reagents for life science and biopharma researchers. The company serves biological and medical science sectors. SomaLogic is headquartered in Boulder, Colorado, the US.

SomaLogic Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SomaLogic Inc, Medical Devices Deals, 2012 to YTD 2018 9
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SomaLogic Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
SomaLogic Raises Funds through Venture Financing 11
SomaLogic Raises USD44.9 in Venture Financing 12
SomaLogic Raises USD163 Million in Venture Financing 13
SomaLogic Raises US$10 Million In Venture Financing 14
Private Equity 15
SomaLogic Raises USD200 Million in Financing Round 15
Partnerships 16
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 16
SomaLogic Inc – Key Competitors 17
SomaLogic Inc – Key Employees 18
SomaLogic Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Apr 02, 2018: Melody Harris, J.D., Appointed Chief Legal Officer of SomaLogic 20
Apr 05, 2017: SomaLogic announces the appointment of long-time Board member as Chief Executive Officer 21
Government and Public Interest 22
Nov 16, 2017: An immune system timeline for tuberculosis progression 22
Oct 16, 2017: Modified DNA aptamer inhibits IL-1 alpha signaling 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
SomaLogic Inc, Pharmaceuticals & Healthcare, Key Facts 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Deals By Therapy Area, 2012 to YTD 2018 8
SomaLogic Inc, Medical Devices Deals, 2012 to YTD 2018 9
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SomaLogic Raises Funds through Venture Financing 11
SomaLogic Raises USD44.9 in Venture Financing 12
SomaLogic Raises USD163 Million in Venture Financing 13
SomaLogic Raises US$10 Million In Venture Financing 14
SomaLogic Raises USD200 Million in Financing Round 15
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 16
SomaLogic Inc, Key Competitors 17
SomaLogic Inc, Key Employees 18

List of Figures
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SomaLogic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SomaLogic Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SomaLogic Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atopix Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • Composites Horizons, Inc.:企業の戦略・SWOT・財務情報
    Composites Horizons, Inc. - Strategy, SWOT and Corporate Finance Report Summary Composites Horizons, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Intrinsic Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intrinsic Therapeutics Inc (Intrinsic) is a medical device company that develops medical devices for the treatment of lumbar disc herniations. The company offers prosthesis for partial anulus replacement following discectomy surgery, prosthesis for partial anulus replacement, and anular clos …
  • Hindustan ZInc Ltd:戦略・SWOT・企業財務分析
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Italgas SpA-石油・ガス分野:企業M&A・提携分析
    Summary Italgas SpA (Italgas), a subsidiary of Snam SpA, is an oilfield service company that offers transportation and dispatching of natural gas, liquefied natural gas regasification, and storage and distribution of natural gas. The company's activities include rhino-analytical tests; instrumental …
  • The British United Provident Association Ltd:企業の戦略的SWOT分析
    The British United Provident Association Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Votorantim SA:企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Aflac Incorporated:企業の戦略・SWOT・財務情報
    Aflac Incorporated - Strategy, SWOT and Corporate Finance Report Summary Aflac Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Techtronic Industries Co Ltd (669):企業の財務・戦略的SWOT分析
    Techtronic Industries Co Ltd (669) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cessna Aircraft Company:企業の戦略・SWOT・財務分析
    Cessna Aircraft Company - Strategy, SWOT and Corporate Finance Report Summary Cessna Aircraft Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Barilla Holding S.p.A.:企業の戦略・SWOT・財務情報
    Barilla Holding S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Barilla Holding S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • vTv Therapeutics Inc (VTVT):企業の財務・戦略的SWOT分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company offers a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases includ …
  • Cardiovascular Systems Inc (CSII):医療機器:M&Aディール及び事業提携情報
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accesso …
  • Suncorp Group Ltd:企業の戦略・SWOT・財務情報
    Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • HDFC Bank Ltd:企業の戦略・SWOT・財務情報
    HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary HDFC Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Madrigal Pharmaceuticals Inc (MDGL):企業の財務・戦略的SWOT分析
    Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Petro Caribbean Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petro Caribbean Resources Ltd (Petro Caribbean Resources) is an oil and gas exploration and development company that offers oil and gas exploration and development of petroleum and natural gas reserves. The company owns and operates oil and gas assets located in Putumayo Basin, Colombia. It …
  • Eisai Inc-製薬・医療分野:企業M&A・提携分析
    Summary Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemoth …
  • Relmada Therapeutics Inc (RLMD):製薬・医療:M&Aディール及び事業提携情報
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆